Ascend Wellness Holdings (AAWH) Cash from Operations (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Cash from Operations of 19411000.0 in Q1 2026, down 218.97% quarter-over-quarter from 16316000.0 in Q4 2025, and down 426.84% on a YoY basis from 5939000.0 in Q1 2025.
Ascend Wellness Holdings (AAWH) Cash from Operations (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash from Operations history runs 7 years deep, the most recent figure standing at 19411000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 426.84% year-over-year to 19411000.0; the TTM figure through Mar 2026 stood at 12703000.0 (down 83.14% YoY), while the FY2025 annual figure was 38053000.0, down 48.08% from the prior year.
- Cash from Operations was 19411000.0 for Q1 2026 at Ascend Wellness Holdings, down from 16316000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 35166000.0 in Q4 2024 to a low of 19411000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 7583058.82 across 5 years, with a median of 5778000.0 in 2023.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations jumped 1644.44% in 2023, then sank 426.84% in 2026.
- A 5-year view of Cash from Operations shows it stood at 16071000.0 in 2022, then soared by 203.71% to 16668000.0 in 2023, then jumped by 110.98% to 35166000.0 in 2024, then sank by 53.6% to 16316000.0 in 2025, then sank by 218.97% to 19411000.0 in 2026.
- The last three Cash from Operations figures came in at 19411000.0 (Q1 2026), 16316000.0 (Q4 2025), and 2003000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -19.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.41 Mn |
| Mar 31, 2026 | -19.41 Mn |
| Dec 31, 2025 | 16.32 Mn |
| Dec 31, 2025 | 16.32 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Dec 31, 2024 | 35.17 Mn |
| Dec 31, 2024 | 35.17 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 16.67 Mn |
| Dec 31, 2023 | 16.67 Mn |